Simultaneous quantitation of serum HBV DNA and HBeAg can distinguish between slow and fast viral responses to antiviral therapy in patients with chronic hepatitis B A quantificação simultânea do DNA VHB e do AgHBe séricos podem distinguir entre resposta viral lenta e rápida à terapêutica anti-viral em pacientes com hepatite crônica B

Simultaneous quantitation of serum HBV DNA and HBeAg can distinguish between slow and fast viral responses to antiviral therapy in patients with chronic hepatitis B A quantificação simultânea do DNA VHB e do AgHBe séricos podem distinguir entre resposta viral lenta e rápida à terapêutica anti-viral em pacientes com hepatite crônica B

BACKGROUND: The quantitation of serum HBeAg is not commonly used to monitor viral response to therapy in chronic hepatitis B. METHODS: In this study, 21 patients receiving varying therapies were followed and their viral response monitored by concomitant viral load and HBeAg quantitation in order to...

Full description

Bibliographic Details
Main Authors: Luiz Caetano da Silva, Maria Luiza da Nova, Suzane Kioko Ono-Nita, João Renato Rebello Pinho, Roberta Sitnik, Vera Aparecida dos Santos, Flair José Carrilho
Format: Article
Language:English
Published: Universidade de São Paulo (USP) 2009-10-01
Series:Revista do Instituto de Medicina Tropical de São Paulo
Subjects:
Hepatitis B
Serological markers
Treatment response
Treatment follow-up
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0036-46652009000500005

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0036-46652009000500005

Similar Items